Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Consideration of postpartum management in HIV-positive Haitian women: an analysis of CD4 decline, mortality, and follow-up after delivery.

Coria A, Noel F, Bonhomme J, Rouzier V, Perodin C, Marcelin A, Li Z, Tosteson TD, Deschamps MM, Wright PF, Pape JW.

J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):636-43. doi: 10.1097/QAI.0b013e31826abdd1.

PMID:
22842846
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.

Liotta G, Mancinelli S, Nielsen-Saines K, Gennaro E, Scarcella P, Magid NA, Germano P, Jere H, Guidotti G, Buonomo E, Ciccacci F, Palombi L, Marazzi MC.

PLoS One. 2013 Aug 19;8(8):e71653. doi: 10.1371/journal.pone.0071653. eCollection 2013. Erratum in: PLoS One. 2013;8(8). doi: 10.1371/annotation/9ab4708e-650e-411a-b72f-bb85e0845469. Gennaro, E [corrected to Gennaro, Elisabetta]; Guidotti, Gianni [corrected to Guidotti, Giovanni].

PMID:
23990966
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.

Pilotto JH, Velasque LS, Friedman RK, Moreira RI, Veloso VG, Grinsztejn B, Morgado MG, Watts DH, Currier JS, Hoffman RM.

Antivir Ther. 2011;16(3):349-56. doi: 10.3851/IMP1779.

PMID:
21555817
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
[PubMed - indexed for MEDLINE]
5.

Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.

Melekhin VV, Shepherd BE, Jenkins CA, Stinnette SE, Rebeiro PF, Bebawy SS, Rasbach DA, Hulgan T, Sterling TR.

AIDS Patient Care STDS. 2010 May;24(5):279-86. doi: 10.1089/apc.2009.0283.

PMID:
20438375
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.

Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W, George K, Richardson P, Zwerski S, Coovadia H, Fowler M; HPTN 046 Protocol Team.

J Acquir Immune Defic Syndr. 2013 Nov 1;64(3):299-306. doi: 10.1097/QAI.0b013e3182a2123a.

PMID:
23846568
[PubMed - indexed for MEDLINE]
7.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

PMID:
17713983
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.

Huet C, Ouedraogo A, Konaté I, Traore I, Rouet F, Kaboré A, Sanon A, Mayaud P, Van de Perre P, Nagot N.

BMC Public Health. 2011 Sep 14;11:700. doi: 10.1186/1471-2458-11-700.

PMID:
21917177
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

PMID:
19832114
[PubMed - indexed for MEDLINE]
Free Article
10.

Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.

Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L.

Trop Med Int Health. 2010 Jul;15(7):825-32. doi: 10.1111/j.1365-3156.2010.02538.x. Epub 2010 May 18.

PMID:
20497405
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
[PubMed - indexed for MEDLINE]
12.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
[PubMed - indexed for MEDLINE]
13.

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort.

Antivir Ther. 2007;12(6):941-7.

PMID:
17926648
[PubMed - indexed for MEDLINE]
14.

Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.

Writing Committee for the CASCADE Collaboration.

Arch Intern Med. 2011 Sep 26;171(17):1560-9. doi: 10.1001/archinternmed.2011.401.

PMID:
21949165
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.

Resino S, Resino R, Micheloud D, Gurbindo Gutiérrez D, Léon JA, Ramos JT, Ciria L, de José I, Mellado J, Muñoz-Fernández A; Spanish Group of Paediatric HIV Infection.

Clin Infect Dis. 2006 Mar 15;42(6):862-9. Epub 2006 Feb 9.

PMID:
16477566
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
[PubMed - indexed for MEDLINE]
Free Article
17.

Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.

Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.

J Infect Dis. 2007 Oct 1;196(7):1044-52. Epub 2007 Aug 29.

PMID:
17763327
[PubMed - indexed for MEDLINE]
Free Article
18.

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.

Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J.

BMC Pediatr. 2007 Mar 17;7:13.

PMID:
17367540
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.

Gutierrez F, Padilla S, Masiá M, Iribarren JA, Moreno S, Viciana P, Muñoz L, Gómez Sirvent JL, Vidal F, López-Aldeguer J, Blanco JR, Leal M, Rodríguez-Arenas MA, Perez Hoyos S; CoRIS-MD.

PLoS One. 2006 Dec 20;1:e89.

PMID:
17183720
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The impact of revised PMTCT guidelines: a view from a public sector ARV clinic in Cape Town, South Africa.

Van Schalkwyk M, Andersson MI, Zeier MD, La Grange M, Taljaard JJ, Theron GB.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):234-8. doi: 10.1097/QAI.0b013e31828bb721.

PMID:
23422849
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk